Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000904454-23-000370
Filing Date
2023-06-06
Accepted
2023-06-06 18:37:47
Documents
1
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 3962
  Complete submission text file 0000904454-23-000370.txt   5553
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 4TH FLOOR BOSTON MA 02116
Business Address
Brenner Randall B. (Reporting) CIK: 0001788249 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36066 | Film No.: 23997290